Joint Formulary & PAD

Tezacaftor with ivacaftor - Cystic fibrosis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
NHSE
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Tezacaftor with ivacaftor
Indication :
Cystic fibrosis
Group Name :
Keywords :
Brand Names Include :
Symkevi
Important Information :
NHSE Specialist Commissioned Services only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Tezacaftor with ivacaftor is used to treat.

  • No records returned.

Committee Recommendations (1)

 This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care